Bortezomib is an anticancer formulation that comprises Atezolizumab, a monoclonal antibody agent. It is used in the treatment of individuals suffering from urothelial carcinoma, small cell lung cancer (SCLC), hepatocellular carcinoma, non-small cell lung cancer (NSCLC), and triple-negative breast cancer (TNBC). This regimen is given as an injection intravenously. Enquire about bortezomib injection on Magicine Pharma and get exclusive deals.
